Catalyst Pharmaceuticals Announces Settlement of FIRDAPSEĀ® (amifampridine) Patent Litigation with Hetero Labs Ltd.

Go back to Catalyst Pharmaceuticals Announces Settlement of FIRDAPSEĀ® (amifampridine) Patent Litigation with Hetero Labs Ltd.
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) Delayed: 31.39 +0.01 (0.03%)
Previous Close $31.38    52 Week High $3.00 
Open $31.38    52 Week Low $0.51 
Day High $31.40    P/E N/A 
Day Low $31.36    EPS $-0.25 
Volume 1,115,287